Drive MedTech Decisions Through AI

Yes. Monitor AI visibility across surgical robotics, imaging systems, diagnostic tools, implants, patient monitoring, point-of-care testing, and digital health platforms. Each category has customized prompt monitoring based on how clinicians and buyers actually evaluate solutions.

Athena continuously monitors how AI platforms describe your device's clinical evidence, regulatory clearance, intended use, and performance benchmarks. When AI outputs diverge from your published data or cleared labeling, your team receives an alert with specific content for review.

Increasingly, yes. While final procurement decisions remain structured, AI is shaping the awareness and shortlisting phase for both clinical champions and administrative buyers. Athena clients see a measurable increase in qualified inbound conversations when their clinical evidence is prominently surfaced by AI.

Athena monitors AI recommendations across 30+ markets and flags region-specific regulatory representation issues; including differences between FDA clearance, CE marking, and country-specific approval status in AI-generated content.